E. Lu et al. / Bioorg. Med. Chem. Lett. 15 (2005) 255–257
6. Jenkins, T. C. Curr. Med. Chem. 2000, 7, 99.
7. Shafer, R. H. Prog. Nucleic AcidRes. Mol. Biol. 1998, 59,
257
30
20
10
55.
8. Giovannangeli, C.; Helene, C. Antisense Nucleic Acid
Drug. Dev. 1997, 7, 413.
´ `
9. Chan, P. P.; Glazer, P. M. J. Mol. Med. 1997, 75, 267.
10. Casey, B. P.; Glazer, P. M. Prog. Nucleic AcidRes. Mol.
Biol. 2001, 67, 163.
11. Antony, T.; Thomas, T.; Sigal, L. H.; Shirahata, A.;
Thomas, T. J. Biochemistry 2001, 40, 9387.
12. Darby, R. A.; Sollogoub, M.; Mckeen, C.; Brown, L.;
Risitiano, A.; Brown, N.; Barton, C.; Brown, T.; Fox, K.
R. Nucleic Acids Res. 2002, 30, e39.
13. de Silva, A. P.; Gunaratne, H. Q. N.; Huxley, A. J.;
McCoy, C. P.; Rademacher, J. T.; Rice, T. E. Chem. Rev.
1997, 97, 1515.
14. Mitchell, K. A.; Brown, R. G.; Yuan, D.; Chang, S.;
Utecht, R. E.; Lewis, D. E. J. Photochem. Photobiol. A
1998, 115, 157.
15. Yuan, D.; Brown, R. G. J. Chem. Res. Synop. 1994, 418;
J. Chem. Res. Miniprint 1994, 2362.
16. Dmitruk, S. L.; Druzhinin, S. I.; Minakova, R. A.; Bedrik,
A. I.; Uzhinov, B. M. Russ. Chem. Bull. 1997, 46, 2027.
17. Bran˜a, M. F.; Ramos, A. Curr. Med. Chem. Anti-Cancer
Agents 2001, 1, 237.
18. Kawai, K.; Kawabata, K.; Tojo, S.; Majima, T. Bioorg.
Med. Chem. Lett. 2002, 12, 2363.
19. de Silva, A. P.; Gunaratne, H. Q. N.; Habib-Jiwan, J.-L.;
McCoy, C. P.; Rice, T. E.; Soumillion, J.-P. Angew.
Chem., Int. Ed. Engl. 1995, 34, 1728.
20. de Silva, A. P.; Rice, T. E. Chem. Commun. 1999, 163.
21. He, H.; Mortellaro, M. A.; Leiner, M. J. P.; Young, S. T.;
Fraatz, R. J.; Tusa, J. K. Anal. Chem. 2003, 75, 549.
22. Wilson, W. D.; Tanious, F. A.; Mizan, S.; Yao, S.;
Kiselyov, A. S.; Zon, G.; Strekowski, L. Biochemistry
1993, 32, 10614.
2
4
6
pH
8
10
Figure 3. Effect of pH on the fluorescence intensity of 1lM 3
(excitation at 457nm, emission from 470to 680nm) at 25 °C.
is about 5.4 obtained from the fluorescence titration
curve (Fig. 3). The fluorescence intensity of 3 decreases
along with the increase of pH value, but when
pH > 6.5, the fluorescence intensity changes very little
in PIPES 20buffer. This pH range might be helpful to
avoid the interference of possible pH change induced
by biological stimulation.28
In summary, a simple fluorescent biosensor 3 for recog-
nition of TÆAT was designed and synthesized, and it dis-
plays selectivity for TÆAT triplex by fluorescence
enhancement when pH > 6.5.
23. Strekowski, L.; Gulevich, Y.; Baranowski, T. C.; Parker,
A. N.; Kiselyov, A. S.; Lin, S. Y.; Tanious, F. A.; Wilson,
W. D. J. Med. Chem. 1996, 39, 3980.
24. Chaires, J. B.; Ren, J.; Henary, M.; Zegrocka, O.; Bishop,
G. R.; Strekowski, L. J. Am. Chem. Soc. 2003, 125, 7272.
25. Strekowski, L.; Zegrocka, O.; Windham, C.; Czarny, A.
Org. Process Res. Dev. 1997, 1, 384.
Acknowledgements
This work was supported by ꢀ973 programꢁ of the Min-
istry of Science and Technology of China and National
Science Foundation of China (project 20128005,
20376010 and 20472012).
26. mp = 233–234°C; 1H NMR (DMSO-d6,400MHz) d 3.22–
3.24 (d, J = 6.0Hz, 2H), 3.34 (s, 3H), 3.53–3.54 (d,
J = 4.2Hz, 2H), 7.03 (s, 1H), 7.08–7.10 (d, J = 7.6Hz,
1H), 7.36–7.38, (d, J = 8.0Hz, 1H), 7.41–7.43 (m, 1H),
7.45–7.46 (m, 1H), 7.48–7.50(m, 1H), 7.52–7.55 (m, 1H),
7.60–7.64, (t, J = 7.6Hz, 1H), 7.91–7.93 (t, J = 8.0Hz,
1H), 7.96–7.98 (d, J = 8.0Hz, 1H), 8.00–8.04, (t,
J = 8.4Hz, 1H), 8.16–8.17, (m, 2H), 8.32–8.34, (m, 2H),
8.38–8.40, (d, J = 8.4Hz, 1H), 8.63, (s, 1H) ppm; HRMS
(ESI) calcd for [M + H]+ 523.2134, found 523.2131.
27. Hopkins, H. P.; Hamilton, D. D.; Wilson, W. D.; Zon, G.
J. Phys. Chem. 1993, 97, 6555.
References and notes
´ `
1. Huong, N. T.; Helene, C. Angew. Chem., Int. Ed. Engl.
1993, 32, 666.
2. Doronina, S. O.; Behr, J.-P. Chem. Soc. Rev. 1997, 63.
3. Neidle, S. Anti-Cancer Drug Des. 1997, 12, 433.
4. Plum, G. E. Biopolymers 1997, 44, 241.
5. Fox, K. R. Curr. Med. Chem. 2000, 7, 17.
28. Li, J.; Eastman, A. J. Biol. Chem. 1995, 270, 3203.